Atom Investors’s Ionis Pharmaceuticals IONS Stock Holding History

Atom Investors’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,669	Closed	-$379K	–	510
2019 Q1	$379K	Buy	+4,669	New	+$301K	0.03%	389

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Atom Investors's IONS Position: Q2 2019 in Review

Atom Investors sold out of Ionis Pharmaceuticals (IONS) in Q2 2019, closing a stake of 4,669 shares — an estimated $379K sold.

Atom Investors first reported a position in IONS in Q1 2019 and held it in 1 quarter. The position peaked at $379K in Q1 2019. 396 funds tracked by Wall St. Rank hold IONS as of Q2 2019.

Atom Investors reported no remaining Ionis Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Atom Investors sold 4,669 Ionis Pharmaceuticals shares in Q2 2019, an estimated $379K.
Atom Investors first reported a position in Ionis Pharmaceuticals in Q1 2019 and held it in 1 quarter.
Atom Investors's Ionis Pharmaceuticals position peaked at $379K in Q1 2019.
396 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2019.

Based on Atom Investors's 13F filing for Q2 2019, filed 14 Aug 2019.